ZA201303359B - Method of treatment with braf inhibitor - Google Patents

Method of treatment with braf inhibitor

Info

Publication number
ZA201303359B
ZA201303359B ZA2013/03359A ZA201303359A ZA201303359B ZA 201303359 B ZA201303359 B ZA 201303359B ZA 2013/03359 A ZA2013/03359 A ZA 2013/03359A ZA 201303359 A ZA201303359 A ZA 201303359A ZA 201303359 B ZA201303359 B ZA 201303359B
Authority
ZA
South Africa
Prior art keywords
treatment
braf inhibitor
braf
inhibitor
Prior art date
Application number
ZA2013/03359A
Inventor
Maureen Bleam
Tona M Gilmer
James G Greger Jr
Sylvie Laquerre
Li Liu
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/061408 external-priority patent/WO2012068468A1/en
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Publication of ZA201303359B publication Critical patent/ZA201303359B/en

Links

ZA2013/03359A 2010-11-12 2013-05-09 Method of treatment with braf inhibitor ZA201303359B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55907210P 2010-11-12 2010-11-12
US41562010P 2010-11-19 2010-11-19
PCT/US2011/061408 WO2012068468A1 (en) 2010-11-19 2011-11-18 Method of treatment with braf inhibitor

Publications (1)

Publication Number Publication Date
ZA201303359B true ZA201303359B (en) 2014-01-29

Family

ID=56369485

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2013/03359A ZA201303359B (en) 2010-11-12 2013-05-09 Method of treatment with braf inhibitor

Country Status (1)

Country Link
ZA (1) ZA201303359B (en)

Similar Documents

Publication Publication Date Title
IL226352A0 (en) Method of treatment with braf inhibitor
IL248530A0 (en) Biomarkers and methods of treatment
ZA201304280B (en) Treatment of jak2-mediated conditions
EP2675458A4 (en) Compounds and methods for treatment of hypertension
EP2773754A4 (en) Method of treatment
GB201110095D0 (en) Method of treatment
EP2603202A4 (en) Compositions and methods for treatment of taupathy
HK1178149A1 (en) Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use -4---
EP2771030A4 (en) Compositions and methods for treatment of proteinopathies
EP2717855A4 (en) Methods of treatment
GB201018147D0 (en) Method of treatment
HUE063599T2 (en) Methods of treatment or reduction of edematous-fibrosclerotic panniculopathy
SG2014014724A (en) METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
IL256026B (en) Methods of treatment
IL220594A0 (en) Treatment method
GB201003920D0 (en) Method of treatment
EP2536709A4 (en) Prolylhydroxylase inhibitors and methods of use
EP2696693A4 (en) Composition and methods for anti-macrofouling treatment of polymers
EP2552915A4 (en) Compounds and method for treatment of hiv
EP2531259A4 (en) Method of treating multiple sclerosis
GB201020045D0 (en) Method for the treatment of biogas
EP2585103A4 (en) Method of treatment
GB201018149D0 (en) Method of treatment
GB201020015D0 (en) Method of treatment
ZA201303359B (en) Method of treatment with braf inhibitor